India's nutraceutical industry, currently valued at approximately $1 billion, is entering a significant transition phase. Industry experts highlight that the future growth and leadership in this sector will increasingly depend on maintaining high standards of quality, ensuring transparency, and substantiating product claims with scientific evidence. This shift reflects growing consumer awareness and regulatory expectations, which are prompting companies to prioritize trust and credibility. As the market scales up, these factors are expected to play a crucial role in shaping competitive dynamics and sustaining long-term success within the Indian nutraceutical landscape. The discussion highlighted how India’s nutraceutical industry is entering a transition phase where quality, transparency and evidence-backed claims could increasingly determine long-term market leadership.